Trials / Completed
CompletedNCT03420677
Enhancement of Sleep With Wearables
Enhancement of Sleep Slow Wave Activity Using Wearable Auditory Stimulation Devices and Its Consequences on Daytime Functioning: a Randomized, Counter-balanced Crossover Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 33 (actual)
- Sponsor
- Swiss Federal Institute of Technology · Academic / Other
- Sex
- All
- Age
- 18 Years – 84 Years
- Healthy volunteers
- Accepted
Summary
Sleep, specifically deep sleep, plays a central role in healthy brain function, cardio-vascular processes, mood and quality of life. Auditory stimulation during one night of sleep has previously been shown to improve deep sleep and along with memory formation in both young and older adults. Yet, it remains unclear whether long-term auditory stimulation considerably improves sleep quality over longer time periods and how it affects daytime functioning such as cognition, mood, quality of life and peripheral functions (e.g. cardio-vascular). Due to the importance of deep sleep for brain and body and the presence of many conditions that involve reduced deep sleep (e.g. ageing) assessing the beneficial impact of long-term sleep enhancement and its consequences is of central interest.This study will assess the effect of auditory stimulation over two weeks (interleaved with a two weeks washout period) in a cohort of healthy young and older adults using portable recording and stimulation devices.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Application of tones | During NREM sleep, tones (max. 60 dB) will be played using a portable, safe, in-home device. This device records biosignals (e.g. brain activity) and precisely times the tones during NREM sleep. It was developed and produced by the ETH Zurich and approved for use in this study by Swissmedic |
| DEVICE | No application of tones | This is the sham-control intervention; The device will only record biosignals but will not play tones. |
Timeline
- Start date
- 2018-05-07
- Primary completion
- 2019-03-05
- Completion
- 2020-10-30
- First posted
- 2018-02-05
- Last updated
- 2021-03-03
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT03420677. Inclusion in this directory is not an endorsement.